Position
SIMPLEX TRADING, LLC in Neurocrine Biosciences Inc
Back to the book · All holders of NBIX
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark −$58.9K$141.83 → $131.74
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 5.84K | $827.9K | — | — | — | 0.0% |
| Q1 2026 | 7.14K | $941.1K | $131.74 | −$58.9K | $172.2K | 0.0% |